Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA)

Historical Holders from Q2 2018 to Q1 2025

Symbol
VRCA on Nasdaq
CUSIP
92511W108
Type / Class
Equity / Common Stock, $0.0001 par value
Shares outstanding
91.4M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
29.9M
Holdings value
$20.9M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
78
Number of buys
38
Number of sells
-35
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Caligan Partners LP 9.99% $7.01M 15.9M Caligan Partners LP Dec 31, 2024
ARMISTICE CAPITAL, LLC 9.99% $4.04M 9.13M Armistice Capital, LLC Dec 31, 2024
PERCEPTIVE ADVISORS LLC 5.1% $2.09M 4.73M Perceptive Advisors LLC Dec 31, 2024

Institutional Holders of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 178K $78.7K -$116K $0.44 6
2024 Q4 29.9M $20.9M +$9.29M $0.70 78
2024 Q3 14.8M $21.5M -$32.4M $1.45 78
2024 Q2 18.6M $136M +$6.59M $7.29 73
2024 Q1 17.7M $105M -$1.51M $5.92 61
2023 Q4 18M $132M +$23.8M $7.32 62
2023 Q3 15.1M $58.5M +$1.49M $3.89 66
2023 Q2 14.6M $84.2M +$9.11M $5.77 63
2023 Q1 12.9M $84.1M +$15M $6.50 59
2022 Q4 10.8M $29.7M -$1.57M $2.75 48
2022 Q3 10.2M $29.9M -$2.47M $2.92 45
2022 Q2 11.2M $21.6M +$4.53M $1.92 50
2022 Q1 8.78M $71.2M -$774K $8.11 45
2021 Q4 8.95M $82M -$7.32M $9.16 42
2021 Q3 9.17M $115M -$8.45M $12.50 49
2021 Q2 9.94M $112M -$1.69M $11.30 53
2021 Q1 9.93M $150M +$15M $15.15 51
2020 Q4 8.95M $103M -$552K $11.51 43
2020 Q3 8.9M $68.9M +$715K $7.74 42
2020 Q2 8.21M $90.4M -$417K $11.01 42
2020 Q1 8.25M $90.2M -$4.84M $10.93 43
2019 Q4 9.19M $144M -$4.19M $15.89 50
2019 Q3 9.26M $137M +$4.28M $14.76 41
2019 Q2 9.02M $105M +$2.57M $11.62 40
2019 Q1 8.8M $96.8M +$5.63M $10.81 38
2018 Q4 8.44M $68.8M -$1.84M $8.15 40
2018 Q3 8.24M $134M -$359K $16.25 44
2018 Q2 8.31M $162M +$162M $19.73 28